16:29:53 EDT Tue 15 Jul 2025
Enter Symbol
or Name
USA
CA



T:TH - THERATECHNOLOGIES INC. - https://www.theratech.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
TH - T  0.14.30·4.313.14.30-0.01-0.258.42471114.32  4.33  4.304.34  1.5915:59:59Jul 0915 min RT 2¢
TSX - T0.14.30·4.313.14.305-0.005-0.124.4103474.32  4.33  4.3054.34  1.5915:59:2915 min
Alpha - A 4.319.44064.31  4.31  4.3115:58:0915 min
Omega - O 4.32+0.010.25.52394.31  4.32  4.3115:35:5715 min
Pure - P 4.310.213    Jul 1415 min
Chi-X - X 4.317.43284.31  4.32  4.3115:49:2015 min
CX2 - H 4.30-0.01-0.23.01354.31  4.32  4.3015:59:5915 min
CXD - D 4.305-0.005-0.13.21484.315  4.32  4.30515:59:2915 min
TriAct - M 4.312.81115    Sep 11/2015 min
Lynx - Y 4.312.61174.31  4.32  4.3115:58:0915 min
CS2 - S 4.310.013    Jul 1015 min

Recent Trades - Last 10 of 111
Time ETExPriceChangeVolumeBuyerSellerMarkers
15:59:59H4.30-0.0120079 CIBC79 CIBCK
15:59:29D4.305-0.0051001 Anonymous79 CIBCK
15:59:29M4.305-0.0051,2001 Anonymous1 Anonymous
15:59:29T4.305-0.00510039 Merrill Lynch1 AnonymousK
15:59:01M4.31 1379 CIBC79 CIBCE
15:58:09A4.31 60019 Desjardins79 CIBCK
15:58:09Y4.31 20019 Desjardins79 CIBCK
15:58:09Y4.31 20019 Desjardins79 CIBCK
15:54:04Y4.31 30019 Desjardins79 CIBCK
15:51:01T4.31 9001 Anonymous7 TD SecK

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolPriceTypeHeadline
2025-07-09 08:12C:TH4.30SEDAR Interim MD & ASEDAR Interim MD & A
2025-07-09 08:06C:TH4.30SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-07-09 07:30C:TH4.30News ReleaseTheratechnologies Reports Financial Results for the Second Quarter 2025
2025-07-03 20:13C:TH4.23News ReleaseTheratechnologies to release Q2 2025 results July 9
2025-07-02 22:11C:TH3.21News ReleaseTheratechnologies enters into Definitive Agreement to be Acquired by CB Biotechnology, an Affiliate of Future Pak
2025-05-29 19:20C:TH3.58News ReleaseTheratechnologies shareholders approve AGM resolutions
2025-05-02 07:30C:TH4.04News ReleaseTheratechnologies Presents Novel Data at ACTHIV 2025 Underscoring Importance of Managing Excess Visceral Abdominal Fat (EVAF) in People with HIV
2025-04-15 19:37C:TH3.71News ReleaseTheratechnologies to continue non-exclusively for sale
2025-04-11 17:44C:TH2.70News ReleaseTheratechnologies, potential acquiror in talks for deal
2025-04-09 08:19C:TH2.21SEDAR Interim Financial StatementsSEDAR Interim Financial Statements
2025-04-09 08:19C:TH2.21SEDAR Interim MD & ASEDAR Interim MD & A
2025-04-09 07:30C:TH2.21News ReleaseTheratechnologies Reports Financial Results for the First Quarter 2025 and Reviews Key Achievements
2025-04-08 16:37C:TH2.21News ReleaseTheratechnologies gets U.S. FDA OK for Egrifta SV PAS
2025-04-03 18:17C:TH2.11News ReleaseTheratechnologies to release Q1 2025 results April 9
2025-03-25 19:25C:TH2.21News ReleaseTheratechnologies receives FDA OK for Egrifta treatment
2025-03-12 14:33C:TH2.18News ReleaseTheratechnologies talks CV study in people with HIV
2025-03-12 14:14C:TH2.18News ReleaseTheratechnologies talks ibalizumab study on HIV RNA
2025-02-26 08:30C:TH2.59SEDAR Annual ReportSEDAR Annual Report
2025-02-26 08:19C:TH2.59SEDAR Audited Annual Financial StatementsSEDAR Audited Annual Financial Statements
2025-02-26 08:19C:TH2.59SEDAR MD & ASEDAR MD & A